Pengaruh Periklanan Dan Personal Selling Terhadap Keputusan Pembelian Skincare Tabita Di Kota Langsa
Jurnal Manajemen Akuntansi (JUMSI) · 2022
DOI: 10.36987/jumsi.v2i4.3830 ↗Kurz gefasst
Fachartikel in der Zeitschrift Jurnal Manajemen Akuntansi (JUMSI), 2022. Verfasst von Yosi Auvitta und 2 weiteren Autor:innen.
Abstract (Originalsprache)
This study aims to examine the impact of advertising and personal selling on the purchasing decisions of Tabita Skincare in Langsa City. This survey uses a sample of 96 respondents. The analytical method used is multiple linear regression analysis, t-test, F-test, and coefficient of decision analysis. Total t-test proves that advertising factor has no significant impact on purchasing decisions for Tabitha Skin Care in Langsa City, and personal selling has a significant impact on purchasing decisions for Tabitha Skin Care in Langsa City. Total F test proves advertising and personal selling factors simultaneously significant effect on purchasing decisions for tabitha skin care in Langsa City. The results of the coefficient of determination test yielded a value of 0,744 or 74,4% of the advertising and personal selling variables influencing the purchasing decision of skin care, while the remaining 25,6% was influenced by other variables not examined in this study.
Zitieren
APA
Auvitta, Y., Junaida, E., & Indah, D. R. (2022). Pengaruh Periklanan Dan Personal Selling Terhadap Keputusan Pembelian Skincare Tabita Di Kota Langsa. Jurnal Manajemen Akuntansi (JUMSI). https://doi.org/10.36987/jumsi.v2i4.3830
Vancouver
Auvitta Y, Junaida E, Indah DR. Pengaruh Periklanan Dan Personal Selling Terhadap Keputusan Pembelian Skincare Tabita Di Kota Langsa. Jurnal Manajemen Akuntansi (JUMSI). 2022. doi:10.36987/jumsi.v2i4.3830
BibTeX
@article{Auvitta2022,
author = {Auvitta, Yosi and Junaida, Erni and Indah, Dewi Rosa},
title = {Pengaruh Periklanan Dan Personal Selling Terhadap Keputusan Pembelian Skincare Tabita Di Kota Langsa},
journal = {Jurnal Manajemen Akuntansi (JUMSI)},
year = {2022},
doi = {10.36987/jumsi.v2i4.3830}
}
EUVIMED